Pediatrix Medical Group (NYSE:MD) Cut to “Sell” at StockNews.com

StockNews.com downgraded shares of Pediatrix Medical Group (NYSE:MD) from a hold rating to a sell rating in a research note issued to investors on Thursday morning.

Other equities analysts have also recently issued research reports about the company. Truist Financial cut their price target on Pediatrix Medical Group from $10.00 to $8.00 and set a hold rating for the company in a report on Monday, July 15th. Deutsche Bank Aktiengesellschaft upgraded Pediatrix Medical Group from a sell rating to a hold rating and set a $8.00 price objective on the stock in a research report on Friday, June 7th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Hold and a consensus target price of $8.70.

Pediatrix Medical Group Price Performance

MD opened at $7.52 on Thursday. The business has a 50 day moving average of $7.41 and a 200-day moving average of $8.61. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.72 and a quick ratio of 1.72. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $15.02.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The firm had revenue of $495.10 million during the quarter, compared to the consensus estimate of $496.25 million. On average, equities analysts expect that Pediatrix Medical Group will post 1.13 EPS for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Several institutional investors have recently bought and sold shares of MD. Performa Ltd US LLC boosted its stake in shares of Pediatrix Medical Group by 130.8% in the 4th quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock valued at $28,000 after purchasing an additional 1,700 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after purchasing an additional 1,524 shares during the last quarter. Counterpoint Mutual Funds LLC boosted its position in Pediatrix Medical Group by 53.4% in the fourth quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock valued at $94,000 after buying an additional 3,528 shares in the last quarter. Virtu Financial LLC bought a new stake in Pediatrix Medical Group during the first quarter worth about $124,000. Finally, Jump Financial LLC acquired a new stake in shares of Pediatrix Medical Group during the fourth quarter worth approximately $154,000. Institutional investors and hedge funds own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.